Nisa Investment Advisors
KMTS

Nisa Investment Advisors’s Kestra Medical Technologies KMTS Stock Holding History

Nisa Investment Advisors’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$509 Hold
20
– – ﹤0.01% 2943
2026
Q1 		$399 Hold
20
– – ﹤0.01% 2889
2025
Q4 		$530 Hold
20
– – ﹤0.01% 2806
2025
Q3 		$475 Buy
+20
New +$358 ﹤0.01% 2863

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Nisa Investment Advisors's KMTS Position: Q2 2026 in Review

Nisa Investment Advisors held its Kestra Medical Technologies (KMTS) position steady in Q2 2026 at 20 shares worth $509. The position accounts for ﹤0.01% of the portfolio, ranked #2943.

Nisa Investment Advisors first reported a position in KMTS in Q3 2025 and has held it in 4 quarters since. The position peaked at $530 in Q4 2025. 109 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Nisa Investment Advisors held 20 shares of Kestra Medical Technologies worth $509 as of Q2 2026.
  • Nisa Investment Advisors left its Kestra Medical Technologies share count unchanged in Q2 2026.
  • Kestra Medical Technologies made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2943 holding.
  • Nisa Investment Advisors first reported a position in Kestra Medical Technologies in Q3 2025 and has held it in 4 quarters since.
  • Nisa Investment Advisors's Kestra Medical Technologies position peaked at $530 in Q4 2025.
  • 109 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.